• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

0.4% 酮咯酸氨丁三醇用于治疗过敏性结膜炎。

Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis.

作者信息

Schechter Barry A

机构信息

Florida Eye Microsurgical Institute, 1717 W Woolbright Road, Boynton Beach, FL 33426, USA.

出版信息

Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):507-11. doi: 10.1517/17425255.4.4.507.

DOI:10.1517/17425255.4.4.507
PMID:18433352
Abstract

BACKGROUND

Acular LS (ketorolac tromethamine 0.4%) ophthalmic solution, a reformulation of the original Acular (ketorolac tromethamine 0.5%), is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.

OBJECTIVE

This manuscript will review the off-label application of this topical NSAID medication as a treatment for allergic conjunctivitis.

METHODS

An extensive MedLine search was undertaken to evaluate data on the use of ketorolac for allergic conjunctivitis. Data on both human and animal data were reviewed.

RESULTS/CONCLUSIONS: Studies have demonstrated that ketorolac 0.4% has equivalent efficacy to ketorolac 0.5%. Several studies have demonstrated that ketorolac effectively treats allergic conjunctivitis. Ketorolac 0.4% is effective when used as either monotherapy or as adjunct therapy to steroids.

摘要

背景

Acular LS(0.4% 酮咯酸氨丁三醇)眼药水是原 Acular(0.5% 酮咯酸氨丁三醇)的重新配方,适用于减轻角膜屈光手术后的眼部疼痛和灼烧/刺痛感。

目的

本文将综述这种局部非甾体抗炎药作为过敏性结膜炎治疗方法的超说明书应用。

方法

进行了广泛的医学文献数据库检索,以评估使用酮咯酸治疗过敏性结膜炎的数据。对人类和动物数据均进行了综述。

结果/结论:研究表明,0.4% 酮咯酸与 0.5% 酮咯酸具有同等疗效。多项研究表明,酮咯酸能有效治疗过敏性结膜炎。0.4% 酮咯酸作为单一疗法或作为类固醇的辅助疗法均有效。

相似文献

1
Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis.0.4% 酮咯酸氨丁三醇用于治疗过敏性结膜炎。
Expert Opin Drug Metab Toxicol. 2008 Apr;4(4):507-11. doi: 10.1517/17425255.4.4.507.
2
Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis.酮咯酸氨丁三醇0.5%滴眼液与安慰剂滴眼液治疗季节性过敏性结膜炎的双盲、配对比较临床研究。
Surv Ophthalmol. 1993 Jul-Aug;38 Suppl:133-40. doi: 10.1016/0039-6257(93)90037-8.
3
An update on the use of ophthalmic ketorolac tromethamine 0.4%.0.4% 眼科用酮咯酸氨丁三醇的应用进展
Expert Opin Pharmacother. 2006 Jan;7(1):99-107. doi: 10.1517/14656566.7.1.99.
4
Results of a survey of patients with ocular allergy treated with topical ketorolac tromethamine.一项关于使用局部用酮咯酸氨丁三醇治疗眼部过敏患者的调查结果。
Clin Ther. 1995 Sep-Oct;17(5):882-90. doi: 10.1016/0149-2918(95)80066-2.
5
Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.0.4% 酮咯酸氨丁三醇滴眼液在准分子激光原位角膜磨镶术后患者中的安全性和有效性
J Cataract Refract Surg. 2004 Aug;30(8):1653-60. doi: 10.1016/j.jcrs.2004.05.019.
6
Efficacy and safety of ketorolac tromethamine 0.5% and levocabastine 0.05%: a multicenter comparison in patients with seasonal allergic conjunctivitis.0.5% 酮咯酸氨丁三醇与 0.05% 左卡巴斯汀的疗效与安全性:季节性过敏性结膜炎患者的多中心比较
Adv Ther. 2000 Mar-Apr;17(2):94-102. doi: 10.1007/BF02854842.
7
Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery.0.4% 外用酮咯酸氨丁三醇用于控制白内障手术相关疼痛或不适的疗效。
Curr Med Res Opin. 2004 Dec;20(12):2015-9. doi: 10.1185/030079904x16759.
8
Comparative study of 0.1% olopatadine hydrochloride and 0.5% ketorolac tromethamine in the treatment of seasonal allergic conjunctivitis.0.1%盐酸奥洛他定与0.5%酮咯酸氨丁三醇治疗季节性变应性结膜炎的对比研究
Acta Ophthalmol Scand. 2003 Aug;81(4):378-82. doi: 10.1034/j.1600-0420.2003.00079.x.
9
Asthma caused by topical application of ketorolac.局部应用酮咯酸引起的哮喘。
Ophthalmology. 1996 Jun;103(6):890-2. doi: 10.1016/s0161-6420(96)30591-5.
10
Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis.0.5% 酮咯酸氨丁三醇滴眼液治疗季节性变应性结膜炎的临床评价
Surv Ophthalmol. 1993 Jul-Aug;38 Suppl:141-8. doi: 10.1016/0039-6257(93)90038-9.

引用本文的文献

1
Current Advances in Mechanisms and Treatment of Dry Eye Disease: Toward Anti-inflammatory and Immunomodulatory Therapy and Traditional Chinese Medicine.干眼症的发病机制与治疗新进展:抗炎和免疫调节治疗与传统中医
Front Med (Lausanne). 2022 Jan 17;8:815075. doi: 10.3389/fmed.2021.815075. eCollection 2021.
2
Comparative study on the efficacy of non-steroidal, steroid and non-use of anti-inflammatory in the treatment of acute epidemic conjunctivitis.非甾体类、甾体类及不使用抗炎药物治疗急性流行性结膜炎的疗效比较研究
Acta Cir Bras. 2020 Feb 7;34(12):e201901206. doi: 10.1590/s0102-865020190120000006. eCollection 2020.